Ligand validation:2I56

RNS: L-RHAMNOSE

RNS is a Ligand Of Interest in 2I56 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2I56_RNS_A_2001	77%	68%	0.11	0.948	0.46	0.75	-	-	0	0	100%	1
2I56_RNS_D_2004	63%	72%	0.116	0.911	0.46	0.6	-	-	0	0	100%	1
2I56_RNS_C_2003	32%	70%	0.175	0.846	0.43	0.72	-	-	1	0	100%	1
2I56_RNS_B_2002	14%	74%	0.205	0.751	0.52	0.49	-	-	3	0	100%	1
3M0H_RNS_A_2001	83%	64%	0.089	0.948	0.47	0.89	-	1	0	0	100%	1
3M0Y_RNS_C_2003	80%	63%	0.097	0.944	0.44	0.95	-	1	0	0	100%	1
4GJI_RNS_C_501	71%	64%	0.094	0.915	0.43	0.92	-	1	0	0	100%	1
3M0V_RNS_A_2001	67%	70%	0.112	0.919	0.48	0.68	-	-	1	0	100%	1
3ITT_RNS_A_2001	43%	65%	0.145	0.869	0.41	0.91	-	1	0	0	100%	1
1X8D_RNS_A_1105	74%	28%	0.117	0.948	1.66	1.22	1	2	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.